These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The use of primary hepatocyte cultures for the evaluation of chemoprotective agents. Morel F; Langouët S; Mahéo K; Guillouzo A Cell Biol Toxicol; 1997 Jul; 13(4-5):323-9. PubMed ID: 9298252 [TBL] [Abstract][Full Text] [Related]
4. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention. Buetler TM; Bammler TK; Hayes JD; Eaton DL Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305 [TBL] [Abstract][Full Text] [Related]
5. A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. Chun YJ; Kim S; Kim D; Lee SK; Guengerich FP Cancer Res; 2001 Nov; 61(22):8164-70. PubMed ID: 11719446 [TBL] [Abstract][Full Text] [Related]
6. Effects of administration of the chemoprotective agent oltipraz on CYP1A and CYP2B in rat liver and rat hepatocytes in culture. Langouët S; Mahéo K; Berthou F; Morel F; Lagadic-Gossman D; Glaise D; Coles B; Ketterer B; Guillouzo A Carcinogenesis; 1997 Jul; 18(7):1343-9. PubMed ID: 9230277 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons. Shimada T; Guengerich FP Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture. Langouët S; Coles B; Morel F; Becquemont L; Beaune P; Guengerich FP; Ketterer B; Guillouzo A Cancer Res; 1995 Dec; 55(23):5574-9. PubMed ID: 7585637 [TBL] [Abstract][Full Text] [Related]
9. Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives. Shimada T; Tanaka K; Takenaka S; Murayama N; Martin MV; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M Chem Res Toxicol; 2010 Dec; 23(12):1921-35. PubMed ID: 21053930 [TBL] [Abstract][Full Text] [Related]
10. Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione. Kwak MK; Itoh K; Yamamoto M; Sutter TR; Kensler TW Mol Med; 2001 Feb; 7(2):135-45. PubMed ID: 11471548 [TBL] [Abstract][Full Text] [Related]
11. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes. Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808 [TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships in the induction of Phase II enzymes by derivatives of 3H-1,2-dithiole-3-thione in rats. Munday R; Zhang Y; Munday CM; Li J Chem Biol Interact; 2006 Mar; 160(2):115-22. PubMed ID: 16458871 [TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inactivation of cytochrome P450s 1A2 and 3A4 by dihydralazine in human liver microsomes. Masubuchi Y; Horie T Chem Res Toxicol; 1999 Oct; 12(10):1028-32. PubMed ID: 10525281 [TBL] [Abstract][Full Text] [Related]
15. Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors. Shimada T; Murayama N; Okada K; Funae Y; Yamazaki H; Guengerich FP Chem Res Toxicol; 2007 Mar; 20(3):489-96. PubMed ID: 17291012 [TBL] [Abstract][Full Text] [Related]
16. 1,2-dithiole-3-thione and its structural analogue oltipraz are potent inhibitors of dibenz. Smith WA; Arif JM; Gupta RC Int J Cancer; 2001 Jan; 91(1):132-6. PubMed ID: 11149412 [TBL] [Abstract][Full Text] [Related]
17. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1. Shimada T; Yamazaki H; Foroozesh M; Hopkins NE; Alworth WL; Guengerich FP Chem Res Toxicol; 1998 Sep; 11(9):1048-56. PubMed ID: 9760279 [TBL] [Abstract][Full Text] [Related]
18. Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase. Oda Y; Aryal P; Terashita T; Gillam EM; Guengerich FP; Shimada T Mutat Res; 2001 May; 492(1-2):81-90. PubMed ID: 11377247 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory monoclonal antibodies to human cytochrome P450 1A2: analysis of phenacetin O-deethylation in human liver. Yang TJ; Sai Y; Krausz KW; Gonzalez FJ; Gelboin HV Pharmacogenetics; 1998 Oct; 8(5):375-82. PubMed ID: 9825829 [TBL] [Abstract][Full Text] [Related]
20. Chemical genomics of cancer chemopreventive dithiolethiones. Tran QT; Xu L; Phan V; Goodwin SB; Rahman M; Jin VX; Sutter CH; Roebuck BD; Kensler TW; George EO; Sutter TR Carcinogenesis; 2009 Mar; 30(3):480-6. PubMed ID: 19126641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]